Physician profile
Kyle Huber
NPI 1730543083
$5,472.06
in general payments reported to CMS, 2019-2025
24 companies · $926 in 2025
The $926 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $151 · 2021: $850 · 2022: $725 · 2023: $977 · 2024: $1,681 · 2025: $926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,583.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,453.54 | 2019-2025 | Grafix Pl, Stravix Pl, Oasis |
| Organogenesis INC. | $652.52 | 2021-2025 | Puraply, Puraply Wound Matrix, Cygnus Dual |
| Urgo Medical North America, LLC | $545.86 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Urgoclean Ag |
| Nevro Corp. | $468.77 | 2022-2024 | Senza |
| Zimmer Biomet Holdings, INC. | $450.00 | 2021-2022 | |
| Solventum Corporation | $197.95 | 2024-2025 | Promogran Prisma, Activ.A.C., Kerramax Care |
| Avita Medical Americas, LLC | $123.88 | 2024-2025 | Recell |
| Melinta Therapeutics, LLC | $112.50 | 2024 | Kimyrsa |
| Convatec INC. | $81.01 | 2021-2024 | |
| Tactile Systems Technology INC | $77.78 | 2020-2025 | Flexitouch Plus, Nimbl |
| Medtronic, INC. | $65.14 | 2021-2025 | Inceptiv |
| Vertex Pharmaceuticals Incorporated | $29.63 | 2024 | |
| Grt US Holding, INC. | $24.43 | 2021 | |
| Ovik Health, LLC | $24.37 | 2025 | Coflex Tlc |
| Integra Lifesciences Corporation | $21.67 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $21.61 | 2021 | |
| Acell, INC. | $17.44 | 2020 | |
| Stimlabs LLC | $16.73 | 2025 | Corplex P |
| Orthofix Medical, INC. | $16.23 | 2022 | |
| Nabriva Therapeutics, Plc | $16.10 | 2021 | |
| Mimedx Group, INC. | $14.65 | 2024 | |
| Polynovo North America LLC | $14.48 | 2025 | Novosorb Btm |
| Dynasplint Systems INC. | $13.59 | 2022 | |
| Celularity INC. | $12.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Huber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.